Zobrazeno 1 - 10
of 53
pro vyhledávání: '"I. Kaimakliotis"'
Autor:
J Tinoco da Silva Torres, P Ellul, S Vieujean, I Ordas, J Burisch, I Mocanu, D Duricova, I Rodríguez-Lago, A Buisson, A Goldis, V Hernandez, N Arebi, I Kaimakliotis, M Nachury, M Fumery, M Allocca, N Pedersen, B Barberio, S Shaji, A Guedes, R Ribeiro, R Ungaro, J Lambert, J F Colombel
Publikováno v:
Journal of Crohn's and Colitis. 17:i443-i444
Background CD is classically seen as a progressive disease leading to bowel damage and disability. Disability has been proposed by the Spirit-IOIBD consensus1 as an endpoint in disease modification trials. However, there is a paucity of data regardin
Autor:
Jean-Frederic Colombel, Dimitrios K. Christodoulou, Mustapha Azahaf, D. Duricova, Philip Lung, Jean-Yves Mary, Johan Burisch, Naila Arebi, Petra Weimers, Adrian Goldis, Jérôme Lambert, Ryan C. Ungaro, Brigida Barberio, Benjamin Pariente, Ian Murphy, Shaji Sebastian, Natalia Pedersen, Joana Torres, Konstantinos H. Katsanos, V Domislović, I. Kaimakliotis, Deirdre McNamara, Pierre Ellul, Martin Horak, Carmelo Lacognata, Željko Krznarić
Background & aims: The Lémann Index is a tool measuring cumulative structural bowel damage in Crohn's disease (CD). We reported on its validation and updating. Methods: This was an international, multicenter, prospective, cross-sectional observation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4da7cebdeab7fb6d15c70c59c4a330
https://www.bib.irb.hr/1253851
https://www.bib.irb.hr/1253851
Autor:
Montserrat Figueira, K R Nielsen, Luciano Sanroman, Ebbe Langholz, Hillel Vardi, Selwyn Odes, Daniela Lazăr, Fernando Magro, Laszlo Lakatos, Riina Salupere, I. Kaimakliotis, Carlos Gonzalez-Portela, Juan-Ramon Pineda, Emma Whitehead, Michael Friger, Niels Thorsgaard, Katherine Ashton, Petra Weimers, Irena Valantiene, Hendrika Adriana Linda Kievit, Vibeke Andersen, Jesús Martínez-Cadilla, Pia Munkholm, Konstantinos H. Katsanos, Peterne Demenyi, Jóngerð Maria Miné Midjord, Karen Kudsk, Adrian Goldis, Jose-Ignacio Rodriguez-Prada, Renata D'Incà, Ruta Kucinskiene, Gediminas Kiudelis, Dimitrios Politis, Pekka Collin, Jens Kjeldsen, M. Giannotta, David Martinez Ares, Corinne Gower-Rousseau, Milan Lukas, Laimas Virginijus Jonaitis, Amalia Carmona, Clays Aalykke, Carl Eriksson, Juozas Kupcinskas, Szabina Nemethne Kramli, Katrine Carlsen, Ulla-Britt Widen, Svetlana Turcan, Martin Bortlik, Birgitte Blichfeldt, Luísa Castro, Zeljko Krznaric, Dana Duricova, Natalia Pedersen, Karina Winther Andersen, Zsuzsanna Vegh, Limas Kupčinskas, Romanas Zykus, Johan Burisch, Alessandro Sartini, Pierre Ellul, Santos Pereira, Vicent Hernandez, V Domislović, Jonas Halfvarson, G. Girardin, Naila Arebi, A. Santini, Alberto Fernandez, Shaji Sebastian, Sally Myers, Doron Schwartz, D. Valpiani, Luísa Barros, Alexandros Skamnelos, Dorte Marker, Stefania Chetcuti Zammit, Silvija Čuković-Čavka, Mathurin Fumery, Jens Frederik Dahlerup, Peter L. Lakatos, Pia Oksanen, Inna Nikulina, Nikša Turk, Anastasia Nicolaou, Dimitrios K. Christodoulou, Elena Belousova, Ida Vind, Olga Shonová, Giualia Dal Piaz
Publikováno v:
The Lancet Gastroenterology & Hepatology
The Lancet Gastroenterology & Hepatology, 2020, 5 (5), pp.454-464. ⟨10.1016/S2468-1253(20)30012-1⟩
Burisch, J, Vardi, H, Schwartz, D, Friger, M, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Lakatos, L, Lakatos, P L, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Arebi, N, Duricova, D, Bortlik, M, Chetcuti Zammit, S, Ellul, P, Pedersen, N, Kjeldsen, J, Midjord, J M M, Nielsen, K R, Winther Andersen, K, Andersen, V, Katsanos, K H, Christodoulou, D K, Domislovic, V, Krznaric, Z, Sebastian, S, Oksanen, P, Collin, P, Barros, L, Magro, F, Salupere, R, Kievit, H A L, Goldis, A, Kaimakliotis, I P, Dahlerup, J F, Eriksson, C, Halfvarson, J, Fernandez, A, Hernandez, V, Turcan, S, Belousova, E, Langholz, E, Munkholm, P, Odes, S & Epi-IBD group 2020, ' Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up : a population-based study ', The Lancet Gastroenterology & Hepatology, vol. 5, no. 5, pp. 454-464 . https://doi.org/10.1016/S2468-1253(20)30012-1
Burisch, J, Vardi, H, Schwartz, D, Friger, M, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Lakatos, L, Lakatos, P L, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Arebi, N, Duricova, D, Bortlik, M, Chetcuti Zammit, S, Ellul, P, Pedersen, N, Kjeldsen, J, Midjord, J M M, Nielsen, K R, Winther Andersen, K, Andersen, V, Katsanos, K H, Christodoulou, D K, Domislovic, V, Krznaric, Z, Sebastian, S, Oksanen, P, Collin, P, Barros, L, Magro, F, Salupere, R, Kievit, H A L, Goldis, A, Kaimakliotis, I P, Dahlerup, J F, Eriksson, C, Halfvarson, J, Fernandez, A, Hernandez, V, Turcan, S, Belousova, E, Langholz, E, Munkholm, P, Odes, S & Epi-IBD group 2020, ' Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up : a population-based study ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 5, pp. 454-464 . https://doi.org/10.1016/S2468-1253(20)30012-1
The Lancet Gastroenterology & Hepatology, 2020, 5 (5), pp.454-464. ⟨10.1016/S2468-1253(20)30012-1⟩
Burisch, J, Vardi, H, Schwartz, D, Friger, M, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Lakatos, L, Lakatos, P L, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Arebi, N, Duricova, D, Bortlik, M, Chetcuti Zammit, S, Ellul, P, Pedersen, N, Kjeldsen, J, Midjord, J M M, Nielsen, K R, Winther Andersen, K, Andersen, V, Katsanos, K H, Christodoulou, D K, Domislovic, V, Krznaric, Z, Sebastian, S, Oksanen, P, Collin, P, Barros, L, Magro, F, Salupere, R, Kievit, H A L, Goldis, A, Kaimakliotis, I P, Dahlerup, J F, Eriksson, C, Halfvarson, J, Fernandez, A, Hernandez, V, Turcan, S, Belousova, E, Langholz, E, Munkholm, P, Odes, S & Epi-IBD group 2020, ' Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up : a population-based study ', The Lancet Gastroenterology & Hepatology, vol. 5, no. 5, pp. 454-464 . https://doi.org/10.1016/S2468-1253(20)30012-1
Burisch, J, Vardi, H, Schwartz, D, Friger, M, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Lakatos, L, Lakatos, P L, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Arebi, N, Duricova, D, Bortlik, M, Chetcuti Zammit, S, Ellul, P, Pedersen, N, Kjeldsen, J, Midjord, J M M, Nielsen, K R, Winther Andersen, K, Andersen, V, Katsanos, K H, Christodoulou, D K, Domislovic, V, Krznaric, Z, Sebastian, S, Oksanen, P, Collin, P, Barros, L, Magro, F, Salupere, R, Kievit, H A L, Goldis, A, Kaimakliotis, I P, Dahlerup, J F, Eriksson, C, Halfvarson, J, Fernandez, A, Hernandez, V, Turcan, S, Belousova, E, Langholz, E, Munkholm, P, Odes, S & Epi-IBD group 2020, ' Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up : a population-based study ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 5, pp. 454-464 . https://doi.org/10.1016/S2468-1253(20)30012-1
BACKGROUND: Inflammatory bowel disease (IBD) places a significant burden on health-care systems because of its chronicity and need for expensive therapies and surgery. With increasing use of biological therapies, contemporary data on IBD health-care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fa90377d26fc1217b6930dac0bce30
https://hal-u-picardie.archives-ouvertes.fr/hal-03551529
https://hal-u-picardie.archives-ouvertes.fr/hal-03551529
Autor:
Ravi Misra, Riina Salupere, Renata D'Incà, Pia Oksanen, Elena Belousova, Jens Kjeldsen, Pekka Collin, Vicent Hernandez, Naila Arebi, Laszlo Lakatos, Luísa Castro, Selwyn Odes, Hendrika Al Kievit, Corinne Gower-Rousseau, Shaji Sebastian, Ebbe Langholz, Jóngerð Midjord, Adrian Goldis, I. Kaimakliotis, Doron Schwartz, Dimitrios K. Christodoulou, Konstantinos H. Katsanos, Zeljko Krznaric, Pierre Ellul, Pia Munkholm, Daniel Bergemalm, Johan Burisch, Kelly Gatt, Juozas Kupcinskas, Jonas Halfvarson, K R Nielsen, Dana Duricova, Vibeke Andersen, Karina Winther Andersen, M. Giannotta, Svetlana Turcan, Martin Bortlik, Gediminas Kiudelis, Mathurin Fumery, Jens Frederik Dahlerup, Peter L. Lakatos, Natalia Pedersen, Fernando Magro, Alessandro Sartini, V Domislović, D. Valpiani, Luísa Barros
Publikováno v:
United European Gastroenterol J
Burisch, J, Bergemalm, D, Halfvarson, J, Domislovic, V, Krznaric, Z, Goldis, A, Dahlerup, J F, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Turcan, S, Belousova, E, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Misra, R, Arebi, N, Duricova, D, Bortlik, M, Gatt, K, Ellul, P, Pedersen, N, Kjeldsen, J, Andersen, K W, Andersen, V, Katsanos, K H, Christodoulou, D K, Sebastian, S, Barros, L, Magro, F, Midjord, J M, Nielsen, K R, Salupere, R, Kievit, H A, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Kaimakliotis, I P, Schwartz, D, Odes, S, Lakatos, L, Lakatos, P L, Langholz, E, Munkholm, P & Epi-IBD group 2020, ' The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up-an Epi-IBD study ', United European Gastroenterology Journal, vol. 8, no. 8, pp. 949-960 . https://doi.org/10.1177/2050640620945949
Burisch, J, Bergemalm, D, Halfvarson, J, Domislovic, V, Krznaric, Z, Goldis, A, Dahlerup, J F, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Turcan, S, Belousova, E, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Misra, R, Arebi, N, Duricova, D, Bortlik, M, Gatt, K, Ellul, P, Pedersen, N, Kjeldsen, J, Andersen, K W, Andersen, V, Katsanos, K H, Christodoulou, D K, Sebastian, S, Barros, L, Magro, F, Midjord, J M M, Nielsen, K R, Salupere, R, Kievit, H A L, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Kaimakliotis, I P, Schwartz, D, Odes, S, Lakatos, L, Lakatos, P L, Langholz, E, Munkholm, P & for the Epi-IBD group 2020, ' The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up : an Epi-IBD study ', United European Gastroenterology Journal, vol. 8, no. 8, pp. 949-960 . https://doi.org/10.1177/2050640620945949
Burisch, J, Bergemalm, D, Halfvarson, J, Domislovic, V, Krznaric, Z, Goldis, A, Dahlerup, J F, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Turcan, S & for the Epi-IBD group 2020, ' The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study ', United European Gastroenterology Journal, vol. 8, no. 8, pp. 949-960 . https://doi.org/10.1177/2050640620945949
United European Gastroenterology Journal
United European Gastroenterology Journal, 2020, 8 (8), pp.949-960. ⟨10.1177/2050640620945949⟩
Burisch, J, Bergemalm, D, Halfvarson, J, Domislovic, V, Krznaric, Z, Goldis, A, Dahlerup, J F, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Turcan, S, Belousova, E, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Misra, R, Arebi, N, Duricova, D, Bortlik, M, Gatt, K, Ellul, P, Pedersen, N, Kjeldsen, J, Andersen, K W, Andersen, V, Katsanos, K H, Christodoulou, D K, Sebastian, S, Barros, L, Magro, F, Midjord, J M, Nielsen, K R, Salupere, R, Kievit, H A, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Kaimakliotis, I P, Schwartz, D, Odes, S, Lakatos, L, Lakatos, P L, Langholz, E, Munkholm, P & Epi-IBD group 2020, ' The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up-an Epi-IBD study ', United European Gastroenterology Journal, vol. 8, no. 8, pp. 949-960 . https://doi.org/10.1177/2050640620945949
Burisch, J, Bergemalm, D, Halfvarson, J, Domislovic, V, Krznaric, Z, Goldis, A, Dahlerup, J F, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Turcan, S, Belousova, E, D'Incà, R, Sartini, A, Valpiani, D, Giannotta, M, Misra, R, Arebi, N, Duricova, D, Bortlik, M, Gatt, K, Ellul, P, Pedersen, N, Kjeldsen, J, Andersen, K W, Andersen, V, Katsanos, K H, Christodoulou, D K, Sebastian, S, Barros, L, Magro, F, Midjord, J M M, Nielsen, K R, Salupere, R, Kievit, H A L, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-Rousseau, C, Kaimakliotis, I P, Schwartz, D, Odes, S, Lakatos, L, Lakatos, P L, Langholz, E, Munkholm, P & for the Epi-IBD group 2020, ' The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up : an Epi-IBD study ', United European Gastroenterology Journal, vol. 8, no. 8, pp. 949-960 . https://doi.org/10.1177/2050640620945949
Burisch, J, Bergemalm, D, Halfvarson, J, Domislovic, V, Krznaric, Z, Goldis, A, Dahlerup, J F, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Turcan, S & for the Epi-IBD group 2020, ' The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study ', United European Gastroenterology Journal, vol. 8, no. 8, pp. 949-960 . https://doi.org/10.1177/2050640620945949
United European Gastroenterology Journal
United European Gastroenterology Journal, 2020, 8 (8), pp.949-960. ⟨10.1177/2050640620945949⟩
BACKGROUND: The lack of scientific evidence regarding the effectiveness of 5-aminosalicylate in patients with Crohn's disease is in sharp contrast to its widespread use in clinical practice.AIMS: The aim of the study was to investigate the use of 5-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b976eb381a6de1e92b92bbf2b2b2f7f
https://doi.org/10.1177/2050640620945949
https://doi.org/10.1177/2050640620945949
Autor:
Johan Burisch, D Mc Namara, Jean-Yves Mary, P Weimars, Pierre Ellul, K.H. Katsanos, Brigida Barberio, Adrian Goldis, P.F. Lung, M Horak, Niels C Pedersen, J Torres, Jean-Frederic Colombel, Naila Arebi, Shaji Sebastian, I Murphy, I. Kaimakliotis, Zeljko Krznaric, Ryan C. Ungaro, Benjamin Pariente, C Lacognata, Dana Duricova, Domislovic
Publikováno v:
Journal of Crohn's and Colitis. 14:S005-S006
Background The Lémann index (LI) is the first instrument developed to measure cumulative structural bowel damage in Crohn’s disease (CD).1 We here report its validation. Methods This was an international, multicentre, prospective cross-sectional o
Autor:
Juan R. Pineda, L. Sanromán, Gregorios A. Paspatis, Selwyn Odes, N. Jojic, Ioannis E. Koutroubakis, Konstantinos Papamichael, Uri Kopylov, Konstantinos H. Katsanos, I. Kaimakliotis, Christien J. van der Woude, Konstantinos Karmiris, Epameinondas V. Tsianos, Konstantina Strongili, Gerassimos J. Mantzaris, D. Bojic, Vicent Hernandez, Neofytos P. Papageorgiou, Shomron Ben-Horin, Dimitrios K. Christodoulou, Gionata Fiorino
Publikováno v:
European Journal of Gastroenterology & Hepatology, 28(7), 802-806. Lippincott Williams & Wilkins
IntroductionMethotrexate (MTX) has been utilized for the treatment of Crohn's disease (CD) for decades. Nevertheless, current data provide equivocal evidence on the efficacy of MTX in CD.The aims of this study were to describe the efficacy of MTX for
Autor:
Selwyn Odes, Riina Salupere, Pekka Collin, Konstantinos H. Katsanos, Dana Duricova, Hendrika Adriana Linda Kievit, I. Kaimakliotis, Jóngerð Midjord, Dimitrios K. Christodoulou, Johan Burisch, Carl Eriksson, Luísa Castro, Ebbe Langholz, Vibeke Andersen, Jonas Halfvarson, Pierre Ellul, Naila Arebi, Pia Oksanen, Pia Munkholm, Shaji Sebastian, K R Nielsen, Elena Belousova, Renata D'Incà, Inna Nikulina, Jens Kjeldsen, Marko Brinar, Limas Kupčinskas, Vicent Hernandez, Gediminas Kiudelis, Karina Winther Andersen, Zsuzsanna Vegh, Alina Toca, Corinne Gower-Rousseau, Svetlana Turcan, Martin Bortlik, Adrian Goldis, Natalia Pedersen, Mathurin Fumery, Peter L. Lakatos, Fernando Magro, Silvija Čuković-Čavka, Ravi Misra, Stefania Chetcuti Zammit, Doron Schwartz, D. Valpiani, Luísa Barros, Sally Myers
Publikováno v:
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, 2019, 13 (2), pp.198-208. ⟨10.1093/ecco-jcc/jjy154⟩
Burisch, J, Katsanos, K H, Christodoulou, D K, Barros, L, Magro, F, Pedersen, N, Kjeldsen, J, Vegh, Z, Lakatos, P L, Eriksson, C, Halfvarson, J, Fumery, M, Gower-Rousseau, C, Brinar, M, Cukovic-Cavka, S, Nikulina, I, Belousova, E, Myers, S, Sebastian, S, Kiudelis, G, Kupcinskas, L, Schwartz, D, Odes, S, Kaimakliotis, I P, Valpiani, D, D'Incà, R, Salupere, R, Zammit, S C, Ellul, P, Duricova, D, Bortlik, M, Goldis, A, Kievit, H A L, Toca, A, Turcan, S, Midjord, J, Nielsen, K R, Andersen, K W, Andersen, V, Misra, R, Arebi, N, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Langholz, E, Munkholm, P & Epi-IBD group 2019, ' Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study ', Journal of Crohn's and Colitis, vol. 13, no. 2, pp. 198–208 . https://doi.org/10.1093/ecco-jcc/jjy154
Burisch, J, Katsanos, K H, Christodoulou, D K, Barros, L, Magro, F, Pedersen, N, Kjeldsen, J, Vegh, Z, Lakatos, P L, Eriksson, C, Halfvarson, J, Fumery, M, Gower-Rousseau, C, Brinar, M, Čuković-Čavka, S, Nikulina, I, Belousova, E, Myers, S, Sebastian, S, Kiudelis, G, Kupcinskas, L, Schwartz, D, Odes, S, Kaimakliotis, I P, Valpiani, D, D'Incà, R, Salupere, R, Chetcuti Zammit, S, Ellul, P, Duricova, D, Bortlik, M, Goldis, A, Kievit, H A L, Toca, A, Turcan, S, Midjord, J, Nielsen, K R, Andersen, K W, Andersen, V, Misra, R, Arebi, N, Oksanen, P, Collin, P, De Castro, L, Hernandez, V, Langholz, E & Munkholm, P 2019, ' Natural Disease Course of Ulcerative Colitis during the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study ', Journal of Crohn's and Colitis, vol. 13, no. 2, pp. 198-208 . https://doi.org/10.1093/ecco-jcc/jjy154
Journal of Crohn's and Colitis, 2019, 13 (2), pp.198-208. ⟨10.1093/ecco-jcc/jjy154⟩
Burisch, J, Katsanos, K H, Christodoulou, D K, Barros, L, Magro, F, Pedersen, N, Kjeldsen, J, Vegh, Z, Lakatos, P L, Eriksson, C, Halfvarson, J, Fumery, M, Gower-Rousseau, C, Brinar, M, Cukovic-Cavka, S, Nikulina, I, Belousova, E, Myers, S, Sebastian, S, Kiudelis, G, Kupcinskas, L, Schwartz, D, Odes, S, Kaimakliotis, I P, Valpiani, D, D'Incà, R, Salupere, R, Zammit, S C, Ellul, P, Duricova, D, Bortlik, M, Goldis, A, Kievit, H A L, Toca, A, Turcan, S, Midjord, J, Nielsen, K R, Andersen, K W, Andersen, V, Misra, R, Arebi, N, Oksanen, P, Collin, P, de Castro, L, Hernandez, V, Langholz, E, Munkholm, P & Epi-IBD group 2019, ' Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study ', Journal of Crohn's and Colitis, vol. 13, no. 2, pp. 198–208 . https://doi.org/10.1093/ecco-jcc/jjy154
Burisch, J, Katsanos, K H, Christodoulou, D K, Barros, L, Magro, F, Pedersen, N, Kjeldsen, J, Vegh, Z, Lakatos, P L, Eriksson, C, Halfvarson, J, Fumery, M, Gower-Rousseau, C, Brinar, M, Čuković-Čavka, S, Nikulina, I, Belousova, E, Myers, S, Sebastian, S, Kiudelis, G, Kupcinskas, L, Schwartz, D, Odes, S, Kaimakliotis, I P, Valpiani, D, D'Incà, R, Salupere, R, Chetcuti Zammit, S, Ellul, P, Duricova, D, Bortlik, M, Goldis, A, Kievit, H A L, Toca, A, Turcan, S, Midjord, J, Nielsen, K R, Andersen, K W, Andersen, V, Misra, R, Arebi, N, Oksanen, P, Collin, P, De Castro, L, Hernandez, V, Langholz, E & Munkholm, P 2019, ' Natural Disease Course of Ulcerative Colitis during the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study ', Journal of Crohn's and Colitis, vol. 13, no. 2, pp. 198-208 . https://doi.org/10.1093/ecco-jcc/jjy154
Background and Aims: Few population-based cohort studies have assessed the disease course of ulcerative colitis [UC] in the era of biological therapy and widespread use of immunomodulators. The aim of this study was to assess the 5-year outcome and d
Autor:
Vibeke Andersen, Péter Lakatos, Vicent Hernandez, Sven Almer, Dana Duricova, I. Kaimakliotis, Ebbe Langholz, Riina Salupere, Mathurin Fumery, Pia Oksanen, K. Ladefoged, Einar Bjornsson, Naila Arebi, Johan Burisch, Svetlana Turcan, K R Nielsen, O Niewiadomski, Fernando Magro, Renata D'Incà, Deirdre McNamara, J.F. Dahlerup, D. Valpiani, Pierre Ellul, Olga Shonová, S. Shaji, Niels C Pedersen, Elena Belousova, Zeljko Krznaric, Pia S. Munkholm, Zsuzsanna Vegh, Jonas Halfvarson, Dimitrios K. Christodoulou, M. Giannotta, Jesús Martínez-Cadilla, Shmuel Odes, Gediminas Kiudelis, Epi-IBD-group, Adrian Goldis, A Kievit
Publikováno v:
Journal of Crohn's and Colitis. 13:S510-S511
Autor:
Svetlana Turcan, Ebbe Langholz, Pia Oksanen, Zeljko Krznaric, Elena Belousova, D. Valpiani, I. Kaimakliotis, Limas Kupčinskas, Naila Arebi, Pia S. Munkholm, Vibeke Andersen, Péter Lakatos, Niels C Pedersen, Epi-IBD, Hillel Vardi, Shmuel Odes, K.H. Katsanos, K R Nielsen, Zsuzsanna Vegh, Renata D'Incà, Shaji Sebastian, Dana Duricova, Dagan Schwartz, Johan Burisch, Jonas Halfvarson, Jens Frederik Dahlerup, Pierre Ellul, Riina Salupere, Mathurin Fumery, Hendrika Adriana Linda Kievit, Fernando Magro, Adrian Goldis, Vicent Hernandez, M. Giannotta
Publikováno v:
Journal of Crohn's and Colitis. 13:S009-S010
Cost analysis in a prospective European population-based inception cohort : is there a cost-saving effect of biological therapy?
Autor:
J. Olsen, Johan Burisch, Svetlana Turcan, L. Barros, K. Kofod Vinding, O Niewiadomski, Gediminas Kiudelis, L de Castro, Pia Munkholm, Alina Jucov, I. Kaimakliotis, K.H. Katsanos, Dana Duricova, K R Nielsen, Renata D'Incà, L Kupcinskap, Laszlo Lakatos, M Beltrami, Sally Bell, Ebbe Langholz, Niels C Pedersen, Adrian Goldis, Zsuzsanna Vegh, D Schwartz, Fernando Magro, Vicent Hernandez, Søren Avnstrøm, EpiCom-group, Shmuel Odes, Peter L. Lakatos, E.V. Tsianos, Martin Bortlik, Daniela Lazăr
Publikováno v:
Journal of Crohn's and Colitis. 9:747-753
Background and Aims: The ECCO-EpiCom study investigates the differences in the incidence and therapeutic management of inflammatory bowel diseases [IBD] between Eastern and Western Europe. The aim of this study was to analyse the differences in the d